Dymon Asia Capital (Singapore)’s Summit Healthcare Acquisition Corp. Class A Ordinary Share SMIH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-300,000
Closed -$2.95M 147
2022
Q3
$2.95M Hold
300,000
0.71% 42
2022
Q2
$2.92M Hold
300,000
0.21% 49
2022
Q1
$22.8M Buy
+300,000
New +$2.9M 1.6% 7

Other funds holding SMIH

Dymon Asia Capital (Singapore)'s SMIH Position: Q4 2022 in Review

Dymon Asia Capital (Singapore) sold out of Summit Healthcare Acquisition Corp. Class A Ordinary Share (SMIH) in Q4 2022, closing a stake of 300,000 shares — an estimated $2.95M sold.

Dymon Asia Capital (Singapore) first reported a position in SMIH in Q1 2022 and held it in 3 quarters. The position peaked at $22.8M in Q1 2022. 37 funds tracked by Wall St. Rank hold SMIH as of Q4 2022.

  • Dymon Asia Capital (Singapore) reported no remaining Summit Healthcare Acquisition Corp. Class A Ordinary Share position as of Q4 2022 after selling out during the quarter.
  • Dymon Asia Capital (Singapore) sold 300,000 Summit Healthcare Acquisition Corp. Class A Ordinary Share shares in Q4 2022, an estimated $2.95M.
  • Dymon Asia Capital (Singapore) first reported a position in Summit Healthcare Acquisition Corp. Class A Ordinary Share in Q1 2022 and held it in 3 quarters.
  • Dymon Asia Capital (Singapore)'s Summit Healthcare Acquisition Corp. Class A Ordinary Share position peaked at $22.8M in Q1 2022.
  • 37 funds tracked by Wall St. Rank held Summit Healthcare Acquisition Corp. Class A Ordinary Share as of Q4 2022.

Based on Dymon Asia Capital (Singapore)'s 13F filing for Q4 2022, filed 13 Feb 2023.